title: Update on the management of dyslipidemia.
abstract: The third edition of guidelines from the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III [ATP III]) is discussed. The most recent classifications for low-density-lipoprotein (LDL) cholesterol, high-density-lipoprotein (HDL), total cholesterol, and triglycerides are provided. LDL cholesterol goals, cardiovascular risk assessment, therapeutic goals, and pharmacologic treatment options are discussed for both primary and secondary prevention of cardiovascular disease. In addition, the management of dyslipidemia in patients with diabetes and metobolic syndrome is addressed, and the differences between the old and new guidelines are highlighted. The ATP III guidelines may help health care professionals to better screen and categorize patients on the basis of their coronary heart disease (CHD) risk. The updated guidelines recommend more intensive lipid-lowering treatments for primary prevention in patients with two or more risk factors.
authors.affiliation: Department of Pharmacy Practice, School of Pharmacy, Texas Tech University Health Sciences Center, Amarillo, TX, USA. brian.irons@ttmc.ttuhsc.edu
authors.forename: Brian K
authors.initials: BK
authors.lastname: Irons
authors.forename: Kathleen A
authors.initials: KA
authors.lastname: Snella
authors.forename: Kenneth
authors.initials: K
authors.lastname: McCall
authors.forename: Eric J
authors.initials: EJ
authors.lastname: MacLaughlin
authors.forename: Maumi
authors.initials: M
authors.lastname: Villarreal
mesh_terms: D000924:Anticholesteremic Agents / Q000627:therapeutic use*; D002784:Cholesterol / Q000097:blood; D008076:Cholesterol, HDL / Q000097:blood; D008078:Cholesterol, LDL / Q000097:blood; D002986:Clinical Trials as Topic; D003327:Coronary Disease / Q000097:blood / Q000209:etiology / Q000517:prevention & control*; D006801:Humans; D006949:Hyperlipidemias / Q000097:blood / Q000188:drug therapy* / Q000517:prevention & control; D008148:Lovastatin / Q000627:therapeutic use; D017410:Practice Guidelines as Topic; D017035:Pravastatin / Q000627:therapeutic use; D018570:Risk Assessment; D012307:Risk Factors
chemical_list: D000924:Anticholesteremic Agents; D008076:Cholesterol, HDL; D008078:Cholesterol, LDL; D002784:Cholesterol; D008148:Lovastatin; D017035:Pravastatin